aTYR PHARMA INC 8-K

What Happened

• On May 15, 2026, aTyr Pharma, Inc. (aTyr) filed a Form 8-K (Item 2.02) to announce its results of operations and financial condition for the quarter ended March 31, 2026.
• The company furnished a press release dated May 15, 2026 as Exhibit 99.1 to the 8-K; the release is incorporated by reference into the filing and contains the detailed quarterly results.

Key Details

• Filing date: May 15, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: quarter ended March 31, 2026.
• Exhibit: 99.1 — Press Release dated May 15, 2026 (financial results furnished).
• Interactive XBRL cover page information was included (Exhibit 104).

Why It Matters

• Quarterly results and the accompanying press release provide the latest earnings and financial-condition information investors use to assess performance, cash runway, revenue trends, and R&D spending.
• Investors should review the furnished press release (Exhibit 99.1) for the specific numbers—revenue, net income/loss, cash balances, and any company commentary or guidance—since the 8-K references those results rather than embedding detailed figures in the body of the filing.